Log in to save to my catalogue

Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in...

Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1932350453

Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in diabetic KKAy mice

About this item

Full title

Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in diabetic KKAy mice

Publisher

Athens: D.A. Spandidos

Journal title

International journal of molecular medicine, 2013-10, Vol.32 (4), p.892-900

Language

English

Formats

Publication information

Publisher

Athens: D.A. Spandidos

More information

Scope and Contents

Contents

Liraglutide, a long-lasting glucagon-like peptide-1 analogue, has been used for the treatment of patients with type 2 diabetes mellitus since 2009. In this study, we investigated the anti-diabetic effects and mechanisms of action of liraglutide in a spontaneous diabetic animal model, using KK/Upj-Ay/J (KKAy) mice. The KKAy mice were divided into 2...

Alternative Titles

Full title

Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in diabetic KKAy mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1932350453

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1932350453

Other Identifiers

ISSN

1107-3756

E-ISSN

1791-244X

DOI

10.3892/ijmm.2013.1453

How to access this item